{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "patients were prospectively enrolled in a randomized trial"
      },
      "Participants": {
        "score": 1,
        "evidence": "stage IV resected melanoma patients"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized trial of adjuvant therapy with a whole-cell melanoma vaccine plus Bacille Calmette-Guerin (BCG) vs. placebo plus BCG"
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To verify circulating tumor cell (CTC) prognostic utility in stage IV resected melanoma patients"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "pretreatment CTC (>0 vs. 0 biomarker) status was significantly associated with disease-free survival (DFS) (HR 1.64, p=0.002) and overall survival (OS) (HR 1.53, p=0.028)"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Blood specimens obtained pretreatment (n=244) and during treatment (n=214)"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "pretreatment CTC (>0 vs. 0 biomarker) status was significantly associated with disease-free survival (DFS) (HR 1.64, p=0.002) and overall survival (OS) (HR 1.53, p=0.028)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Study registration ID# NCT00052156"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  },
  "model": "gpt-4o"
}